Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein. (Q53317312)

13 May 2018

title

Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein. (English)

1 reference

13 May 2018

7

Wagner F Gattaz

1 reference

13 May 2018

author name string

Evelin L Schaeffer

1

1 reference

13 May 2018

Vanessa J De-Paula

2

1 reference

13 May 2018

Emanuelle R da Silva

3

1 reference

13 May 2018

Barbara de A Novaes

4

1 reference

13 May 2018

Heni D Skaf

5

1 reference

13 May 2018

Orestes V Forlenza

6

1 reference

13 May 2018

publication date

9 March 2011

1 reference

13 May 2018

Journal of Neural Transmission

published in

1 reference

13 May 2018

volume

118

1 reference

13 May 2018

issue

9

1 reference

13 May 2018

page(s)

1273-1279

1 reference

13 May 2018

SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: Role of resveratrol

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Distinct roles in signal transduction for each of the phospholipase A2 enzymes present in P388D1 macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

On the binding preference of human groups IIA and X phospholipases A2 for membranes with anionic phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Extinction of morphine-dependent conditioned behavior is associated with increased phosphorylation of the GluR1 subunit of AMPA receptors at hippocampal synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity is increased in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

The growing phospholipase A2 superfamily of signal transduction enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Inhibition of phospholipase A2 increases tau phosphorylation at Ser214 in embryonic rat hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Microtubule formation and neurite growth in cerebellar macroneurons which develop in vitro: evidence for the involvement of the microtubule-associated proteins, MAP-1a, HMW-MAP2 and Tau

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Decreased phospholipase A2 activity in Alzheimer brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radioimmuno-slot-blot assay for nanograms of the protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Ligand-dependent tau filament formation: implications for Alzheimer's disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Differential assembly of human tau isoforms in the presence of arachidonic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Cerebrospinal fluid biomarkers and prediction of conversion in patients with mild cognitive impairment: 4-year follow-up in a routine clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

The human calcium-independent phospholipase A2 gene multiple enzymes with distinct properties from a single gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Multiple splice variants of the human calcium-independent phospholipase A2 and their effect on enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Irreversible inhibition of Ca(2+)-independent phospholipase A2 by methyl arachidonyl fluorophosphonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

The genomic organization, complete mRNA sequence, cloning, and expression of a novel human intracellular membrane-associated calcium-independent phospholipase A(2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Distinct arachidonate-releasing functions of mammalian secreted phospholipase A2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

The C2 domain calcium-binding motif: structural and functional diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Identification of novel cytosolic phospholipase A(2)s, murine cPLA(2){delta}, {epsilon}, and {zeta}, which form a gene cluster with cPLA(2){beta}

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Both total and phosphorylated tau are increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Decreased phospholipase A2 activity in cerebrospinal fluid of patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Molecular characterization of cytosolic phospholipase A2-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

A novel calcium-independent phospholipase A2, cPLA2-gamma, that is prenylated and contains homology to cPLA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Regional distribution, ontogeny, purification, and characterization of the Ca2+-independent phospholipase A2 from rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-011-0619-4

Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain

21 January 2018

1 reference

12 December 2020

Increased tau protein differentiates mild cognitive impairment from geriatric depression and predicts conversion to dementia

1 reference

12 December 2020

Association of total tau and phosphorylated tau 181 protein levels in cerebrospinal fluid with cerebral atrophy in mild cognitive impairment and Alzheimer disease

1 reference

12 December 2020

Inhibition of calcium-independent phospholipase A2 activity in rat hippocampus impairs acquisition of short- and long-term memory

1 reference

12 December 2020

Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease.

1 reference

12 December 2020

Sense and antisense transfection analysis of tau function: tau influences net microtubule assembly, neurite outgrowth and neuritic stability.

1 reference

12 December 2020

Independent folding and ligand specificity of the C2 calcium-dependent lipid binding domain of cytosolic phospholipase A2

1 reference

12 December 2020

Phospholipase A2 structure/function, mechanism, and signaling

1 reference

12 December 2020

Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease.

1 reference

12 December 2020

A frontal variant of Alzheimer's disease exhibits decreased calcium-independent phospholipase A2 activity in the prefrontal cortex

1 reference

12 December 2020

Diversity of group types, regulation, and function of phospholipase A2

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity

1 reference

12 December 2020

10.1007/S00702-011-0619-4

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018